BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 32650561)

  • 1. Distinct Microbiota Dysbiosis in Patients with Non-Erosive Reflux Disease and Esophageal Adenocarcinoma.
    Zhou J; Shrestha P; Qiu Z; Harman DG; Teoh WC; Al-Sohaily S; Liem H; Turner I; Ho V
    J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32650561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of the esophageal microbiota in Barrett's esophagus and esophageal adenocarcinoma.
    Lv J; Guo L; Liu JJ; Zhao HP; Zhang J; Wang JH
    World J Gastroenterol; 2019 May; 25(18):2149-2161. PubMed ID: 31143067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Role of the Microbiome in Barrett's Esophagus and Esophageal Adenocarcinoma.
    Snider EJ; Freedberg DE; Abrams JA
    Dig Dis Sci; 2016 Aug; 61(8):2217-2225. PubMed ID: 27068172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resident Esophageal Microbiota Dysbiosis Correlates with Cancer Risk in Barrett's Esophagus Patients and Is Linked to Low Adherence to WCRF/AICR Lifestyle Recommendations.
    Zaramella A; Arcidiacono D; Nucci D; Fabris F; Benna C; Pucciarelli S; Fassan M; Fantin A; De Re V; Cannizzaro R; Realdon S
    Nutrients; 2023 Jun; 15(13):. PubMed ID: 37447211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-erosive and erosive gastroesophageal reflux diseases: No difference with regard to reflux pattern and motility abnormalities.
    Martínek J; Benes M; Hucl T; Drastich P; Stirand P; Spicák J
    Scand J Gastroenterol; 2008; 43(7):794-800. PubMed ID: 18584517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations to the Esophageal Microbiome Associated with Progression from Barrett's Esophagus to Esophageal Adenocarcinoma.
    Snider EJ; Compres G; Freedberg DE; Khiabanian H; Nobel YR; Stump S; Uhlemann AC; Lightdale CJ; Abrams JA
    Cancer Epidemiol Biomarkers Prev; 2019 Oct; 28(10):1687-1693. PubMed ID: 31466948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acid and bile reflux in erosive reflux disease, non-erosive reflux disease and Barrett's esophagus.
    Hak NG; Mostafa M; Salah T; El-Hemaly M; Haleem M; Abd El-Raouf A; Hamdy E
    Hepatogastroenterology; 2008; 55(82-83):442-7. PubMed ID: 18613384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Esophageal microbiome signature in patients with Barrett's esophagus and esophageal adenocarcinoma.
    Lopetuso LR; Severgnini M; Pecere S; Ponziani FR; Boskoski I; Larghi A; Quaranta G; Masucci L; Ianiro G; Camboni T; Gasbarrini A; Costamagna G; Consolandi C; Cammarota G
    PLoS One; 2020; 15(5):e0231789. PubMed ID: 32369505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms.
    Reavis KM; Morris CD; Gopal DV; Hunter JG; Jobe BA
    Ann Surg; 2004 Jun; 239(6):849-56; discussion 856-8. PubMed ID: 15166964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between alcohol and reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
    Anderson LA; Cantwell MM; Watson RG; Johnston BT; Murphy SJ; Ferguson HR; McGuigan J; Comber H; Reynolds JV; Murray LJ
    Gastroenterology; 2009 Mar; 136(3):799-805. PubMed ID: 19162028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Esophageal Microbiome in Health and Disease.
    Corning B; Copland AP; Frye JW
    Curr Gastroenterol Rep; 2018 Aug; 20(8):39. PubMed ID: 30069679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haplotypes of the IL-1 gene cluster are associated with gastroesophageal reflux disease and Barrett's esophagus.
    Izakovicova Holla L; Borilova Linhartova P; Hrdlickova B; Marek F; Dolina J; Rihak V; Kala Z
    Hum Immunol; 2013 Sep; 74(9):1161-9. PubMed ID: 23806268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive dysbiosis of human orodigestive microbiota along the sequence of gastroesophageal reflux, Barrett's esophagus and esophageal adenocarcinoma.
    Hao Y; Karaoz U; Yang L; Yachimski PS; Tseng W; Nossa CW; Ye W; Tseng M; Poles M; Francois F; Traube M; Brown SM; Chen Y; Torralba M; Peek RM; Brodie EL; Pei Z
    Int J Cancer; 2022 Nov; 151(10):1703-1716. PubMed ID: 35751398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Microbiota in Esophageal Adenocarcinoma: Pathogenesis, Diagnosis, Prognosis and Therapeutic Implications.
    Dan W; Peng L; Yan B; Li Z; Pan F
    Front Microbiol; 2021; 12():791274. PubMed ID: 35126331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-erosive reflux disease (NERD)--acid reflux and symptom patterns.
    Martinez SD; Malagon IB; Garewal HS; Cui H; Fass R
    Aliment Pharmacol Ther; 2003 Feb; 17(4):537-45. PubMed ID: 12622762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superficial Esophageal Mucosal Afferent Nerves May Contribute to Reflux Hypersensitivity in Nonerosive Reflux Disease.
    Woodland P; Shen Ooi JL; Grassi F; Nikaki K; Lee C; Evans JA; Koukias N; Triantos C; McDonald SA; Peiris M; Aktar R; Blackshaw LA; Sifrim D
    Gastroenterology; 2017 Nov; 153(5):1230-1239. PubMed ID: 28734832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Helicobacter pylori infection in 190 control subjects and in 236 patients with gastroesophageal reflux, erosive esophagitis or Barrett's esophagus.
    Csendes A; Smok G; Cerda G; Burdiles P; Mazza D; Csendes P
    Dis Esophagus; 1997 Jan; 10(1):38-42. PubMed ID: 9079272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bile reflux in benign and malignant Barrett's esophagus: effect of medical acid suppression and nissen fundoplication.
    Stein HJ; Kauer WK; Feussner H; Siewert JR
    J Gastrointest Surg; 1998; 2(4):333-41. PubMed ID: 9841990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonerosive reflux disease.
    Long JD; Orlando RC
    Minerva Gastroenterol Dietol; 2007 Jun; 53(2):127-41. PubMed ID: 17557041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Esophageal mucosal innervation in functional heartburn: Closer to healthy asymptomatic subjects than to non-erosive reflux disease patients.
    Nikaki K; Woodland P; Lee C; Ghisa M; Marinelli C; Savarino E; Sifrim D
    Neurogastroenterol Motil; 2019 Sep; 31(9):e13667. PubMed ID: 31225933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.